InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Crockett Thomas Andrew, Chief Executive Officer. Director active across 1 company, notably KalVista Pharmaceuticals, Inc.. Cumulatively, 19 reports have been published. Split: 0 buy · 8 sells. Total volume traded: €1.9m. History available since 29 April 2021. The latest transaction was filed on 14 February 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Crockett Thomas Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
54,415 sharesCommon StockSEC:0001415889-24-004710:0
58,356 shares@ US$15.009334.0% of flowCommon StockSEC:0001415889-24-004120:0
122,500 sharesCommon StockSEC:0001415889-24-003475:0
9,300 shares@ US$16.17515.8% of flowCommon StockSEC:0001415889-24-002625:0
30,000 shares@ US$12.015113.6% of flowCommon StockSEC:0001209191-23-059907:0
33,583 sharesCommon StockSEC:0001209191-23-056267:0
8,000 shares0Common StockSEC:0001209191-23-054018:0
33,582 sharesCommon StockSEC:0001209191-23-046820:0
12,750 sharesCommon StockSEC:0001209191-23-031292:0
12,749 sharesCommon StockSEC:0001209191-23-012315:0
5,805 sharesCommon StockSEC:0001209191-22-058119:0
6,500 shares0Common StockSEC:0001209191-22-049030:0
5,805 sharesCommon StockSEC:0001209191-22-046855:0
10,000 shares@ US$17.06938.1% of flowCommon StockSEC:0001209191-22-018184:0
10,000 shares@ US$17.18417.7% of flowCommon StockSEC:0001209191-21-059042:0
4,350 shares@ US$23.87874.6% of flowCommon StockSEC:0001209191-21-045093:0
1,067 shares@ US$30.0381.4% of flowCommon StockSEC:0001209191-21-042450:0
8,933 shares@ US$30.054911.5% of flowCommon StockSEC:0001209191-21-040040:0
4,750 shares0Common StockSEC:0001209191-21-036588:0
19 of 19 declarations
About Crockett Thomas Andrew
Crockett Thomas Andrew is Directeur Général at KalVista Pharmaceuticals, Inc. (XNAS). He has filed 19 filings in total, and in the sampled recent filings from 2021-05-28 to 2024-02-21, the transactions are all sales, for a total of EUR 1,923,610.
